Literature DB >> 30030792

Treatment of HIV for the Prevention of Transmission in Discordant Couples and at the Population Level.

M Kumi Smith1, Britta L Jewell2, Timothy B Hallett3, Myron S Cohen4.   

Abstract

The scientific breakthrough proving that antiretroviral therapy (ART) can halt heterosexual HIV transmission came in the form of a landmark clinical trial conducted among serodiscordant couples. Study findings immediately informed global recommendations for the use of treatment as prevention in serodiscordant couples. The extent to which these findings are generalizable to other key populations or to groups exposed to HIV through nonsexual transmission routes (i.e., anal intercourse or unsafe injection of drugs) has since driven a large body of research. This review explores the history of HIV research in serodiscordant couples, the implications for management of couples, subsequent research on treatment as prevention in other key populations, and challenges in community implementation of these strategies.

Keywords:  HIV transmission; Serodiscordant couples; Treatment as prevention

Mesh:

Substances:

Year:  2018        PMID: 30030792     DOI: 10.1007/978-981-13-0484-2_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Incidence of complications and revision surgery in HAART compliant HIV patients undergoing primary total hip and knee arthroplasty: an institutional review.

Authors:  Roshan Jacob; Kelly Chandler; Nick Medawar; Mackenzie Sowers; Gerald McGwin; Sameer Naranje
Journal:  Arch Orthop Trauma Surg       Date:  2022-09-09       Impact factor: 2.928

2.  Evaluation of a Novel In-house HIV-1 Genotype Drug Resistance Assay using Clinical Samples in China.

Authors:  Peijie Gao; Fengting Yu; Xiaozhen Yang; Dan Li; Yalun Shi; Yan Wang; Fujie Zhang
Journal:  Curr HIV Res       Date:  2022       Impact factor: 1.341

3.  Survey of antiretroviral therapy adherence and predictors of poor adherence among HIV patients in a tertiary institution in Nigeria.

Authors:  Adekunle Olatayo Adeoti; Mobolaji Dada; Tobiloba Elebiyo; Joseph Fadare; Opeyemi Ojo
Journal:  Pan Afr Med J       Date:  2019-07-31

4.  Understanding the Risks and Benefits of a Patient Portal Configured for HIV Care: Patient and Healthcare Professional Perspectives.

Authors:  Dominic Chu; David Lessard; Moustafa A Laymouna; Kim Engler; Tibor Schuster; Yuanchao Ma; Nadine Kronfli; Jean-Pierre Routy; Tarek Hijal; Karine Lacombe; Nancy Sheehan; Hayette Rougier; Bertrand Lebouché
Journal:  J Pers Med       Date:  2022-02-19

Review 5.  Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies.

Authors:  Barton F Haynes; Kevin Wiehe; Persephone Borrrow; Kevin O Saunders; Bette Korber; Kshitij Wagh; Andrew J McMichael; Garnett Kelsoe; Beatrice H Hahn; Frederick Alt; George M Shaw
Journal:  Nat Rev Immunol       Date:  2022-08-12       Impact factor: 108.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.